Additional file 2: of Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models

Table S1 Analysis of HLA type in PDX BCM-2147/-4913 and CD34+ HSCs. HLA typing was performed by using PCR-SSO DNA-based procedures. The serological phenotype is an interpretation based on molecular typing data. ND Not determined. Table S2 Gene expression analysis (RNA-Seq) comparing MC1, BCM-2147, and BCM-4913 PDXs growing in nonhumanized vs. humanized NSG mice. Differentially expressed genes (DEGs) were selected by edge R-based p value and fold change (FC). Supplemental Methods. (DOCX 22 kb